
Biotechnology · NSE
Sheel Biotech Limited, incorporated in November 1991, specializes in biotechnology, floriculture, greenhouses, and organic farming. The company produces high-quality, disease-free plants for fruits, vegetables, ornamentals, and field crops using tissue culture and hydroponics, and provides greenhouse manufacturing, farmer services, and training through FPOs. It also offers landscaping services to government and private clients and holds ISO certifications for quality, environment, and safety. Its R&D lab is recognized by India’s Department of Biotechnology and Department of Science and Technology. Sheel Biotech supports organic farming adoption, manages FPOs, implements turnkey horticultural projects with modern technologies, and conducts training programs for farmers and agripreneurs. As of September 30, 2024, it had 160 permanent employees.
Price Band
₹59 – ₹63
Issue Size
₹34.02 Cr
Lot Size
2000 shares
GMP
+23.8%
Est. Listing
₹78
at current GMP
Subscribed
16.05x
overall
Open
30 Sep 2025
Close
3 Oct 2025
Allotment
6 Oct 2025
Refund
7 Oct 2025
Demat Credit
8 Oct 2025
Listing
8 Oct 2025
Last updated: 21 Nov 2025
Current Premium
Issue Price (Upper)
₹63
Band: ₹59 – ₹63
Estimated Listing Price
₹78
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,26,000
Estimated Profit / Lot
₹30,000
2000 × ₹15
Grey Market Premium trend
+₹15
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹15 | 23.8% | ₹78 |
| 30 Oct 2026 | +₹15 | 23.8% | ₹78 |
| 29 Oct 2026 | +₹14 | 21.4% | ₹77 |
GMP is unofficial market data. Not a guarantee of listing performance.
Sheel Biotech Limited is bringing an initial public offering (IPO) in the Biotechnology sector with an aggregate issue size of ₹34.02 Crores. The shares are offered at a price band of ₹59 to ₹63 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,26,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Skyline Financial Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-10-08, while un-allotted funds or UPI block mandates will be released on 2025-10-07.
The latest grey market premium for Sheel Biotech Limited IPO is ₹15, which indicates an expected listing price of ₹78.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.